Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CSTL Q1 2018 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$772M

Q1 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4M

Gross Profit

$2M65.8% margin

Operating Income

-$3M-84.3% margin

Net Income

-$4M-99.2% margin

EPS (Diluted)

$-0.34

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$61,707

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

-$14M

Cash & Equivalents

-$1M

← FY 2018 All Quarters Q2 2018 →